Kamau Therapeutics has raised $20 million to enhance its gene correction platform, aiming to improve...
$20M
Kamau Therapeutics has secured $20 million in funding to enhance its gene correction platform, aimin...
Ocugen has secured $30 million in funding to enhance transformative biotech treatments, aiming to im...
$30M
Phlox Therapeutics has secured $1.9 million in funding to enhance gene therapy options for cardiomyo...
$1.9M
